Abstract
Jaundice is a common condition in neonates, occurring in 60% to 84% of late term and term infants. Phototherapy is considered as a treatment of choice since many years in the management of unconjugated hyperbilirubinemia. Phototherapy is the use of visible light to treat severe jaundice in the neonatal period. Treatment with phototherapy is implemented in order to prevent the neurotoxic effects of high serum unconjugated bilirubin. Different types of phototherapy delivery system are in use. Bili blanket phototherapy uses fiberoptic systems that reduces or eliminates all of the potential complications of conventional phototherapy and facilitates establishment of an enhanced parent-infant bond.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
